Vector A.I.

Vector Biopharma is a precision gene therapy company focused on overcoming the limitations of current viral delivery systems. Utilizing its proprietary SHIELD platform, the company engineers high-capacity adenoviral vectors that are designed to be cell-specific, immune-evasive, and capable of delivering large genetic payloads. This technology aims to enable the systemic administration of gene therapies for a wide range of indications, including oncology and rare genetic diseases. By combining computational design with advanced protein engineering, Vector Biopharma seeks to transform the safety and efficacy profile of genetic medicines.